Factors associated with sinus bradycardia during crizotinib treatment: a retrospective analysis of two large‐scale multinational trials (PROFILE 1005 and 1007)

بواسطة Ou, Sai‐Hong Ignatius, Tang, Yiyun, Polli, Anna, Wilner, Keith D., Schnell, Patrick
الحاوية / القاعدة Cancer Med (2016)

Effect of the patient information brochure in communicating the risks associated with crizotinib treatment to patients with non‐small cell lung cancer (NSCLC) in Europe

بواسطة Huang, Kui, Madison, Terri, Wehler, Beatrice, Tiseo, Marcello, Wilner, Keith D., Mo, Jingping
الحاوية / القاعدة Pharmacol Res Perspect (2020)

Pharmacokinetics and pharmacodynamics of the leukotriene B(4) receptor antagonist CP-105,696 in man following single oral administration

بواسطة Liston, Theodore E, Conklyn, Maryrose J, Houser, Janet, Wilner, Keith D, Johnson, Arlene, Apseloff, Glen, Whitacre, Caroline, Showell, Henry J
منشور في 1998

Crizotinib versus Chemotherapy in Asian Patients with ALK-Positive Advanced Non-small Cell Lung Cancer

بواسطة Nishio, Makoto, Kim, Dong-Wan, Wu, Yi-Long, Nakagawa, Kazuhiko, Solomon, Benjamin J., Shaw, Alice T., Hashigaki, Satoshi, Ohki, Emiko, Usari, Tiziana, Paolini, Jolanda, Polli, Anna, Wilner, Keith D., Mok, Tony
الحاوية / القاعدة Cancer Res Treat (2018)

Palbociclib has no clinically relevant effect on the QTc interval in patients with advanced breast cancer

بواسطة Durairaj, Chandrasekar, Ruiz-Garcia, Ana, Gauthier, Eric R., Huang, Xin, Lu, Dongrui R., Hoffman, Justin T., Finn, Richard S., Joy, Anil A., Ettl, Johannes, Rugo, Hope S., Zheng, Jenny, Wilner, Keith D., Wang, Diane D.
الحاوية / القاعدة Anticancer Drugs (2018)

Complex renal cysts associated with crizotinib treatment

بواسطة Schnell, Patrick, Bartlett, Cynthia H, Solomon, Benjamin J, Tassell, Vanessa, Shaw, Alice T, de Pas, Tommaso, Lee, Soo-Hyun, Lee, Geon Kook, Tanaka, Kaoru, Tan, Weiwei, Tang, Yiyun, Wilner, Keith D, Safferman, Allan, Han, Ji-Youn
الحاوية / القاعدة Cancer Med (2015)

Updated Overall Survival in a Randomized Study Comparing Dacomitinib with Gefitinib as First-Line Treatment in Patients with Advanced Non-Small-Cell Lung Cancer and EGFR-Activating...

بواسطة Mok, Tony S., Cheng, Ying, Zhou, Xiangdong, Lee, Ki Hyeong, Nakagawa, Kazuhiko, Niho, Seiji, Chawla, Alka, Rosell, Rafael, Corral, Jesus, Migliorino, Maria Rita, Pluzanski, Adam, Noonan, Kay, Tang, Yiyun, Pastel, Malaika, Wilner, Keith D., Wu, Yi-Long
الحاوية / القاعدة Drugs (2020)

Clinical Experience With Crizotinib in Patients With Advanced ALK-Rearranged Non–Small-Cell Lung Cancer and Brain Metastases

بواسطة Costa, Daniel B., Shaw, Alice T., Ou, Sai-Hong I., Solomon, Benjamin J., Riely, Gregory J., Ahn, Myung-Ju, Zhou, Caicun, Shreeve, S. Martin, Selaru, Paulina, Polli, Anna, Schnell, Patrick, Wilner, Keith D., Wiltshire, Robin, Camidge, D. Ross, Crinò, Lucio
الحاوية / القاعدة J Clin Oncol (2015)

MET Amplification Identifies a Small and Aggressive Subgroup of Esophagogastric Adenocarcinoma With Evidence of Responsiveness to Crizotinib

بواسطة Lennerz, Jochen K., Kwak, Eunice L., Ackerman, Allison, Michael, Michael, Fox, Stephen B., Bergethon, Kristin, Lauwers, Gregory Y., Christensen, James G., Wilner, Keith D., Haber, Daniel A., Salgia, Ravi, Bang, Yung-Jue, Clark, Jeffrey W., Solomon, Benjamin J., Iafrate, A. John
منشور في 2011

Modernizing Clinical Trial Eligibility Criteria: Recommendations of the ASCO-Friends of Cancer Research Performance Status Work Group

بواسطة Magnuson, Allison, Bruinooge, Suanna S., Singh, Harpreet, Wilner, Keith D., Jalal, Shadia, Lichtman, Stuart M., Kluetz, Paul G., Lyman, Gary H., Klepin, Heidi D., Fleury, Mark E., Hirsch, Brad, Melemed, Allen, Arnaldez, Fernanda I., Roy, Upal Basu, Schenkel, Caroline, Sherwood, Shimere, Garrett-Mayer, Elizabeth
الحاوية / القاعدة Clin Cancer Res (2021)

Final results of the large-scale multinational trial PROFILE 1005: efficacy and safety of crizotinib in previously treated patients with advanced/metastatic ALK-positive non-small-...

بواسطة Blackhall, Fiona, Ross Camidge, D, Shaw, Alice T, Soria, Jean-Charles, Solomon, Benjamin J, Mok, Tony, Hirsh, Vera, Jänne, Pasi A, Shi, Yuankai, Yang, Pan-Chyr, Pas, Tommaso De, Hida, Toyoaki, Carpeño, Javier De Castro, Lanzalone, Silvana, Polli, Anna, Iyer, Shrividya, Reisman, Arlene, Wilner, Keith D, Kim, Dong-Wan
الحاوية / القاعدة ESMO Open (2017)

Crizotinib in ALK-Rearranged Inflammatory Myofibroblastic Tumor

بواسطة Butrynski, James E., D’Adamo, David R., Hornick, Jason L., Cin, Paola Dal, Antonescu, Cristina R., Jhanwar, Suresh C., Ladanyi, Marc, Capelletti, Marzia, Rodig, Scott J., Ramaiya, Nikhil, Kwak, Eunice L., Clark, Jeffrey W., Wilner, Keith D., Christensen, James G., Jänne, Pasi A., Maki, Robert G., Demetri, George D., Shapiro, Geoffrey I.
منشور في 2010

ROS1 Rearrangements Define a Unique Molecular Class of Lung Cancers

بواسطة Bergethon, Kristin, Shaw, Alice T., Ignatius Ou, Sai-Hong, Katayama, Ryohei, Lovly, Christine M., McDonald, Nerina T., Massion, Pierre P., Siwak-Tapp, Christina, Gonzalez, Adriana, Fang, Rong, Mark, Eugene J., Batten, Julie M., Chen, Haiquan, Wilner, Keith D., Kwak, Eunice L., Clark, Jeffrey W., Carbone, David P., Ji, Hongbin, Engelman, Jeffrey A., Mino-Kenudson, Mari, Pao, William, Iafrate, A. John
منشور في 2012

Acquired Resistance to Crizotinib from a Mutation in CD74–ROS1

بواسطة Awad, Mark M., Katayama, Ryohei, McTigue, Michele, Liu, Wei, Deng, Ya-Li, Brooun, Alexei, Friboulet, Luc, Huang, Donghui, Falk, Matthew D., Timofeevski, Sergei, Wilner, Keith D., Lockerman, Elizabeth L., Khan, Tahsin M., Mahmood, Sidra, Gainor, Justin F., Digumarthy, Subba R., Stone, James R., Mino-Kenudson, Mari, Christensen, James G., Iafrate, A. John, Engelman, Jeffrey A., Shaw, Alice T.
منشور في 2013

Crizotinib in ROS1-Rearranged Non–Small-Cell Lung Cancer

بواسطة Shaw, Alice T., Ou, Sai-Hong I., Bang, Yung-Jue, Camidge, D. Ross, Solomon, Benjamin J., Salgia, Ravi, Riely, Gregory J., Varella-Garcia, Marileila, Shapiro, Geoffrey I., Costa, Daniel B., Doebele, Robert C., Le, Long Phi, Zheng, Zongli, Tan, Weiwei, Stephenson, Patricia, Shreeve, S. Martin, Tye, Lesley M., Christensen, James G., Wilner, Keith D., Clark, Jeffrey W., Iafrate, A. John
الحاوية / القاعدة N Engl J Med (2014)

Effect of crizotinib on overall survival in patients with advanced non-small-cell lung cancer harbouring ALK gene rearrangement: a retrospective analysis

بواسطة Shaw, Alice T, Yeap, Beow Y, Solomon, Benjamin J, Riely, Gregory J, Gainor, Justin, Engelman, Jeffrey A, Shapiro, Geoffrey I, Costa, Daniel B, Ou, Sai-Hong I, Butaney, Mohit, Salgia, Ravi, Maki, Robert G, Varella-Garcia, Marileila, Doebele, Robert C, Bang, Yung-Jue, Kulig, Kimary, Selaru, Paulina, Tang, Yiyun, Wilner, Keith D, Kwak, Eunice L, Clark, Jeffrey W, Iafrate, A John, Camidge, D Ross
منشور في 2011